Novavax (NVAX) Interest & Investment Income (2010 - 2021)
Novavax (NVAX) posted quarterly Interest & Investment Income of $303000.0 for Q4 2021, up 113.38% year-over-year from $142000.0 in Q4 2020, and down 8.18% quarter-over-quarter from $330000.0 in Q3 2021.
Powered by 
Analysis
Novavax (NVAX) Interest & Investment Income (2010 - 2021) Analysis & Trends
Novavax's Interest & Investment Income history runs 12 years deep, the most recent figure standing at $303000.0 for Q4 2021.
- In Q4 2021, Interest & Investment Income rose 113.38% year-over-year to $303000.0; the TTM figure through Dec 2021 stood at $1.4 million (up 34.38% YoY), while the FY2021 annual figure was $1.4 million, up 34.52% from the prior year.
- Interest & Investment Income for Q4 2021 stood at $303000.0, down from $330000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $807000.0 in Q2 2018, with the low at $140000.0 in Q3 2020.
- The 5-year median for Interest & Investment Income is $419000.0 (2017), against an average of $425550.0.
- The sharpest annual moves came in 2017 and 2021: Interest & Investment Income slumped 68.78% in 2017, then jumped 135.71% in 2021.
- Novavax's Interest & Investment Income stood at $418000.0 in 2017, then surged by 39.71% to $584000.0 in 2018, then sank by 52.74% to $276000.0 in 2019, then sank by 48.55% to $142000.0 in 2020, then surged by 113.38% to $303000.0 in 2021.
- Business Quant data shows NVAX's Interest & Investment Income at $303000.0 in Q4 2021, $330000.0 in Q3 2021, and $369000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Novavax | 1.67 Bn | 953.49 Mn | 42.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 303,000.00 |
| Sep 30, 2021 | 330,000.00 |
| Jun 30, 2021 | 369,000.00 |
| Mar 31, 2021 | 362,000.00 |
| Dec 31, 2020 | 142,000.00 |
| Sep 30, 2020 | 140,000.00 |
| Jun 30, 2020 | 297,000.00 |
| Mar 31, 2020 | 436,000.00 |
| Dec 31, 2019 | 276,000.00 |
| Sep 30, 2019 | 342,000.00 |
| Jun 30, 2019 | 474,000.00 |
| Mar 31, 2019 | 420,000.00 |
| Dec 31, 2018 | 584,000.00 |
| Sep 30, 2018 | 752,000.00 |
| Jun 30, 2018 | 807,000.00 |
| Mar 31, 2018 | 531,000.00 |
| Dec 31, 2017 | 418,000.00 |
| Sep 30, 2017 | 531,000.00 |
| Jun 30, 2017 | 523,000.00 |
| Mar 31, 2017 | 474,000.00 |